Long-term Outcomes Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Abstract

Achieving a node-negative status is the major determinant of outcome following neoadjuvant chemoradiotherapy. Histomorphologic tumor regression is less predictive of outcome than pathologic nodal status (ypN), and the need to include a primary site regression score in a new staging classification is unclear.